Literature DB >> 26827712

Keloids: Animal models and pathologic equivalents to study tissue fibrosis.

Jaana Marttala1, Jonathan P Andrews1, Joel Rosenbloom2, Jouni Uitto3.   

Abstract

Animal models are crucial for the study of fibrosis. Keloids represent a unique type of fibrotic scarring that occurs only in humans, thus presenting a challenge for those studying the pathogenesis of this disease and its therapeutic options. Here, several animal models of fibrosis currently in use are described, emphasizing recent progress and highlighting encouraging challenges.
Copyright © 2016 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Hypertrophic scar; Keloids; Tissue fibrosis

Mesh：

Substances：

Year:  2016        PMID： 26827712      PMCID： PMC4842112          DOI： 10.1016/j.matbio.2016.01.014

Source DB:  PubMed          Journal:  Matrix Biol        ISSN： 0945-053X            Impact factor:   11.583


  44 in total

1.  Use of nude (athymic) mice for the study of hypertrophic scars and keloids: vascular continuity between mouse and implants.

Authors:  C W Kischer; D Sheridan; J Pindur
Journal:  Anat Rec       Date:  1989-11

2.  Equine exuberant granulation tissue and human keloids: a comparative histopathologic study.

Authors:  Christine L Theoret; Oluyinka O Olutoye; Laura K S Parnell; John Hicks
Journal:  Vet Surg       Date:  2013-09-09       Impact factor: 1.495

Review 3.  Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

Authors:  Manuel Rubio-Rivas; Cristina Royo; Carmen Pilar Simeón; Xavier Corbella; Vicent Fonollosa
Journal:  Semin Arthritis Rheum       Date:  2014-05-14       Impact factor: 5.532

Review 4.  Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives.

Authors:  Sara Ud-Din; Susan W Volk; Ardeshir Bayat
Journal:  Exp Dermatol       Date:  2014-07-21       Impact factor: 3.960

5.  Tissue engineering for in vitro analysis of matrix metalloproteinases in the pathogenesis of keloid lesions.

Authors:  Hanwei Li; Zayna Nahas; Felicia Feng; Jennifer H Elisseeff; Kofi Boahene
Journal:  JAMA Facial Plast Surg       Date:  2013 Nov-Dec       Impact factor: 4.611

6.  Tissue replacement in the rabbit's ear.

Authors:  J Joseph; M Dyson
Journal:  Br J Surg       Date:  1966-04       Impact factor: 6.939

7.  Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.

Authors:  Lutz Wollin; Isabelle Maillet; Valérie Quesniaux; Alexander Holweg; Bernhard Ryffel
Journal:  J Pharmacol Exp Ther       Date:  2014-02-20       Impact factor: 4.030

8.  The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration.

Authors:  P J Christner; J Peters; D Hawkins; L D Siracusa; S A Jiménez
Journal:  Arthritis Rheum       Date:  1995-12

9.  Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.

Authors:  Amélie Servettaz; Claire Goulvestre; Niloufar Kavian; Carole Nicco; Philippe Guilpain; Christiane Chéreau; Vincent Vuiblet; Loïc Guillevin; Luc Mouthon; Bernard Weill; Frédéric Batteux
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

10.  Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model.

Authors:  Hakan Uzun; Ozan Bitik; Rümeysa Hekimoğlu; Pergin Atilla; Aycan Uğur Kaykçoğlu
Journal:  Plast Reconstr Surg       Date:  2013-09       Impact factor: 4.730
View more
  13 in total

1.  LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.

Authors:  Yun Liu; Lei Li; Jia-Yao Wang; Fei Gao; Xia Lin; Shi-Shuai Lin; Zhi-Yang Qiu; Zun-Hong Liang
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842

2.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

Review 3.  Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.

Authors:  Jonathan P Andrews; Jaana Marttala; Edward Macarak; Joel Rosenbloom; Jouni Uitto
Journal:  Matrix Biol       Date:  2016-02-02       Impact factor: 11.583

Review 4.  Keloids: a review of therapeutic management.

Authors:  Samuel F Ekstein; Saranya P Wyles; Steven L Moran; Alexander Meves
Journal:  Int J Dermatol       Date:  2020-09-09       Impact factor: 3.204

5.  Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.

Authors:  N Jumper; T Hodgkinson; R Paus; A Bayat
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

Review 6.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

7.  Adiponectin-Based Peptide (ADP355) Inhibits Transforming Growth Factor-β1-Induced Fibrosis in Keloids.

Authors:  Claudia C Darmawan; Sara E Montenegro; Gwanghyun Jo; Novi Kusumaningrum; Si-Hyung Lee; Jin-Ho Chung; Je-Ho Mun
Journal:  Int J Mol Sci       Date:  2020-04-18       Impact factor: 5.923

8.  Cartilage-like composition of keloid scar extracellular matrix suggests fibroblast mis-differentiation in disease.

Authors:  Javier Barallobre-Barreiro; Elizabeth Woods; Rachel E Bell; Jennifer A Easton; Carl Hobbs; Michael Eager; Ferheen Baig; Alastair Mackenzie Ross; Raj Mallipeddi; Barry Powell; Mark Soldin; Manuel Mayr; Tanya J Shaw
Journal:  Matrix Biol Plus       Date:  2019-10-30

Review 9.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

10.  MicroRNA-21 may be involved in the therapeutic effects of Galla chinensis ointment on keloid.

Authors:  Zhiming Tang; Jicun Ding; Xiaoxiang Zhai; Mengqing Jing; Zhiqiang Guan; Yongcong Li
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.